Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_assertion type Assertion NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_head.
- NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_assertion description "[IGF-II LOI was evident in 7 of 17 (41%) UCB tumors and 4 of 11 (36%) tumor-associated normal urothelial samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_provenance.
- NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_assertion evidence source_evidence_literature NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_provenance.
- NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_assertion SIO_000772 18980977 NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_provenance.
- NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_assertion wasDerivedFrom befree-2016 NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_provenance.
- NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_assertion wasGeneratedBy ECO_0000203 NP701378.RAnw2LSGP3Dm6SESPQvdaYdXGkBBWDnZISuj4yew9DSxY130_provenance.